// App-Quantinova.ai

4106 : Plasma biomarker for detection of early-stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-A2 isoforms.

Researchers

Presenter

  • Kazufumi Honda

Principal Investigators

  • Michimoto Kobayashi

  • Takuji Okusaka

  • Chigusa Morizane

  • Jo Ann Rinaudo

  • Ying Huang

  • Tracey Marsh

  • Masashi Shimahara

  • Takaaki Ueno

  • Akihiko Tsuchida

  • Naohiro Sata

  • Tatsuya Ioka

  • Tomoo Kosuge

  • Yohichi Yasunami

  • Masaru Yoshida

  • Takeshi Azuma

  • Sudhir Srivastava

  • Tesshi Yamada

Medical Centers

  • National Cancer Center Research Institute, Tokyo, Japan

  • New Frontiers Research Laboratories, Toray Industries, Inc., Kamakura, Japan

  • Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan

  • National Institute of Health, Gaithersburg, MD

  • Public Health Science Division, Fred Hutchinson Cancer Center, Seattle, WA

  • Public Health Science Division, Fred Hutchinson Cancer Center, Seattle, WA

  • Department of Oral Surgery, Osaka Medical College, Takatsuki, Japan

  • Department of Gastroenterological and Pediatric Surgery, Tokyo, Japan

  • Department of Surgery, Jichi Medical University School of Medicine, Shimotsuke, Japan

  • Hepatobiliary and Pancreatic Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan

  • National Cancer Center Hospital, Tokyo, Japan

  • Department of Regenerative Medicine and Transplantation, Fukuoka University, Fukuoka, Japan

  • Department of Gastroenterology, Graduate School of Medicine Kobe University, Kobe, Japan

  • Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan

  • National Human Genome Research Institute, National Institutes of Health, Bethesda, MD

  • National Cancer Center Research Institute, Tokyo, Japan

Locations

  • United States

  • Japan

Companies

  • Toray Industries, In

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved